ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday expressed its concerns over track-and-trace systems in its comments submitted to the U.S. Senate Health, Education, Labor and Pensions Committee hearing, “Securing the Pharmaceutical Supply Chain.”
"NCPA continues to feel that track-and-trace technologies remain largely unproven and such a system may prove to be prohibitively expensive for independent community pharmacies," stated Douglas Hoey, NCPA EVP and CEO. "We have identified a number of essential elements that should be considered as any proposed track and trace system is developed."
The NCPA had the following recommendations for the federal government:
“NCPA believes that the U.S. pharmaceutical supply chain is safe and secure,” Hoey said. “There are a number of different tactics or approaches that could provide further assurances of integrity — including efforts to combat pharmaceutical cargo theft and the implementation of national, uniform federal license standards for drug wholesalers.”